Electrical Stimulators Market – By Product (Transcutaneous Electrical Nerve, Neuromuscular Electric, Spinal Cord Stimulators, Deep Brain Stimulators), Application (Pain Management, Neuromodulation, Aesthetics), End-user - Global Forecast (2024 – 2032)

Electrical Stimulators Market Size

Electrical Stimulators Market was valued at USD 3.8 billion in 2023 and is anticipated to grow at a CAGR of around 10% between 2024 and 2032. Electrical stimulators are medical devices that deliver controlled electrical impulses to specific nerves or muscles in the body. These devices are designed for therapeutic purposes, aiming to elicit physiological responses for various medical applications. The electrical stimulators industry is propelled by the increasing prevalence of neurodegenerative disorders and the untapped potential of neuro-stimulation for disease management.
 

According to the National Center of Biotechnology Information (NCBI) article, Parkinson's incidence among individuals aged 65 and older in North America ranges from 108 to 212 per 100,000, and for those aged 45 and older, it ranges from 47 to 77 per 100,000. This rising prevalence creates a growing patient pool with unmet medical needs, fueling the demand for effective treatments. Electrical stimulators are emerging as a viable and evolving therapeutic option, meeting the demand for innovative solutions in the healthcare landscape.
 

Furthermore, the electrical stimulators market is experiencing significant growth driven by the rise in sedentary lifestyles and the demand for convenient muscle toning methods. Modern sedentary behaviors, often associated with office work and increased screen time, contribute to health issues like muscle weakness and stiffness. Additionally, busy schedules make regular exercise challenging. This lifestyle shift has created a demand for efficient muscle toning solutions, with electrical stimulation emerging as a convenient and time-effective alternative.

COVID-19 Impact

The COVID-19 pandemic had a detrimental impact on the electrical stimulators market, with global healthcare resources redirected to combat the virus. Elective procedures, including those involving electrical stimulators, were postponed due to COVID-19-related care prioritization and resource conservation. Economic uncertainties led to delayed treatments as individuals faced job security concerns, and disruptions in the global supply chain and manufacturing limitations hindered the production and distribution of medical devices, affecting the availability of electrical stimulators. These multifaceted challenges collectively led to a downturn in the market during the pandemic.
 

Electrical Stimulators Market Trends

The high demand for alternatives to traditional pain management drugs has become a pivotal factor for the promising growth of the electrical stimulators industry.
 

• Many individuals seek alternatives to traditional pain medications due to concerns about side effects, dependency, and potential long-term consequences associated with pharmaceuticals. Whereas the electrical stimulators offer a non-pharmacological and drug-free approach to pain management, propelling the market growth.
   
• Furthermore, technological advancements in electrical stimulators play a pivotal role as a driving factor in the electrical stimulators industry. These advancements contribute to the development of more sophisticated, user-friendly, and effective devices, fostering innovation and expanding the market's capabilities.
   
• For instance, Longest Science & Technology Co., Ltd developed a MStim Sport LGT-232, a smart, wireless Bluetooth connectivity muscle stimulator for athletes and fitness enthusiasts.
   
• These innovations enhance the therapeutic capabilities of electrical stimulators and contribute significantly to the continued growth and acceptance of these devices in diverse healthcare applications.
   

Electrical Stimulators Market Analysis

The market by product is categorized into transcutaneous electrical nerve stimulator, neuromuscular electric stimulator, deep brain stimulation devices, spinal cord stimulator, and other products. The deep brain stimulation devices segment held a substantial revenue share in the electrical stimulators market, accounting for 32.5% in 2023.
 

• Deep brain stimulation is applicable across a range of neurological conditions, making it a versatile intervention. Its use extends beyond Parkinson’s disease to manage other conditions such as movement disorders, obsessive-compulsive disorder (OCD), essential tremors, and epilepsy.
   
• Furthermore, ongoing studies to explore the applications of DBS in other neurological and cerebral conditions is driving the growth of this segment.
   

Based on applications, the market unfolds into distinctive domains such as physiotherapy /pain management, aesthetics, and neuromodulation. The physiotherapy/pain management segment dominated the market with 45.2% market share in 2023 and is projected to reach USD 4.1 billion by the end of 2032.
 

• Electrical stimulators offer versatility in addressing various types of pain, including neuropathic pain, musculoskeletal pain, and inflammatory pain.
   
• Physiotherapy professionals can tailor the use of electrical stimulators to different pain conditions. High scope for customization is one of the major factors boosting the success rate, and adoption of these devices.
   
• Additionally, the growth of this segment is driven by demand-side factors such as high prevalence of chronic pain conditions, versatility in pain management, and the clinical expertise of physiotherapy professionals.
   

Based on end-use, the market unfolds its segmentation, encompassing the domains of hospitals, clinics, home care, and other end-users. The hospital segment accounted for a substantial market share of 45.9% in the global electrical stimulators industry.
 

• Hospitals are the primary end-users in the electrical stimulators market due to their pivotal role in comprehensive healthcare delivery and skills and infrastructure required in deep brain stimulation procedures.
   
• With a diverse range of medical specialties and clinical expertise, hospitals are well-equipped to diagnose and address a broad spectrum of medical conditions.
   
• Furthermore, the versatility of electrical stimulators makes them valuable in treating various health issues, such as neurological disorders, musculoskeletal conditions, chronic pain, and rehabilitation needs.
   
• Therefore, these factors are expected to be substantial contributors to the market’s growth.
   

U.S. market accounted for USD 980.5 million revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The prevalence of chronic conditions such as chronic pain, neurological disorders, and musculoskeletal issues is on the rise in U.S. Electrical stimulators are effective in managing these conditions, leading to increased demand in the region.
   
• In U.S., a large population follows sedentary lifestyle leading to muscle atrophy.  According to the Centers for Disease Control and Prevention (CDC), in 2020, around 15% of US adults were physically inactive.
   
• These factors collectively aid in increasing the market share of U.S. in global electrical stimulators industry.
   

Electrical Stimulators Market Share

The electrical stimulators industry is consolidated, with key players including Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories majorly dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in August 2023, Medtronic received CE (Conformité Européenne) Mark approval for its Inceptiv spinal cord stimulator, featuring closed-loop sensing technology for the treatment of chronic pain. This stimulator stands as a first Medtronic SCS device incorporating a closed-loop feature that senses each person's unique biological signals and adjusts stimulation moment to moment as per the requirement. This innovative capability allowed the company to deliver device catering personalized care. The approval of this product enhanced the company’s competitive positioning in Europe.
 

Electrical Stimulators Market Companies

Some of the eminent market participants operating in the electrical stimulators industry include:

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• BTL Corporate
• Zynex, Inc
• HMS Medical Systems
• OMRON Corporation
• BioMedical Life Systems
• HASOMED GmbH
• Saluda Medical Pty Ltd
   

Electrical Stimulators Industry News

• In October 2023, FDA approved expanded indication for the WaveWriter Alpha spinal cord stimulator systems from Boston Scientific. This approval now allows to use WaveWriter Alpha SCS to treat painful diabetic peripheral neuropathy. This approval allowed the company to enter a new therapeutic area and increase the product sales.
   
• In May 2023, the spinal cord stimulation (SCS) systems of Abbott Laboratories received U.S. FDA approval for the treatment of chronic back pain in individuals who have not had or are not eligible to receive back surgery. This approval of expanded indication helped the company to enhance their customer base and reputation.
   

Electrical stimulators market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Transcutaneous electrical nerve stimulator
• Neuromuscular electric stimulator
• Deep brain stimulation devices
• Spinal cord stimulator
• Other products

Market, By Application

• Physiotherapy /Pain management
• Aesthetics
• Neuromodulation

Market, By End-use

• Hospitals
• Clinics
• Home care
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa